MECOM and leukemia: The detailed mechanistic understanding and the functional implications of transcription levels and protein turnover, which could be mediated by ubiquitination, sumoylation or other posttranslational modifications, and dynamic spatiotemporal interactions of EVI1 will be a critical consideration for targeted therapeutic approaches in EVI1 overexpressing leukaemia.